AI assistant
CONMED Corp — Director's Dealing 2021
Jun 3, 2021
31971_dirs_2021-06-03_24d1877b-4999-40df-8d5c-766c2abd1ee6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2021-06-01
Reporting Person: Aronson Martha Goldberg (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-06-01 | Common Stock | M | 1521 | — | Acquired | 10463 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-06-01 | Rsus (restricted Stock Units) | $0 | M | 1521 | Disposed | 2030-06-01 | Common Stock (1521) | Direct |
| 2021-06-01 | Rsus (restricted Stock Units) | $0 | A | 812 | Acquired | 2031-06-01 | Common Stock (812) | Direct |
| 2021-06-01 | Options To Purchase Common Stock | $138.45 | A | 865 | Acquired | 2031-06-01 | Common Stock (865) | Direct |
Footnotes
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.
F2: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.